• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶 G 的调节可减少来自 1 型糖尿病患者的前胰岛素反应性 T 细胞的激活。

Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients.

机构信息

Division of Endocrinology and Diabetes, Center for Internal Medicine, University Medical Center Ulm, Ulm, Germany.

出版信息

PLoS One. 2011;6(8):e22815. doi: 10.1371/journal.pone.0022815. Epub 2011 Aug 5.

DOI:10.1371/journal.pone.0022815
PMID:21850236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3151250/
Abstract

Autoantigenic peptides resulting from self-proteins such as proinsulin are important players in the development of type 1 diabetes mellitus (T1D). Self-proteins can be processed by cathepsins (Cats) within endocytic compartments and loaded to major histocompatibility complex (MHC) class II molecules for CD4(+) T cell inspection. However, the processing and presentation of proinsulin by antigen-presenting cells (APC) in humans is only partially understood. Here we demonstrate that the processing of proinsulin by B cell or myeloid dendritic cell (mDC1)-derived lysosomal cathepsins resulted in several proinsulin-derived intermediates. These intermediates were similar to those obtained using purified CatG and, to a lesser extent, CatD, S, and V in vitro. Some of these intermediates polarized T cell activation in peripheral blood mononuclear cells (PBMC) from T1D patients indicative for naturally processed T cell epitopes. Furthermore, CatG activity was found to be elevated in PBMC from T1D patients and abrogation of CatG activity resulted in functional inhibition of proinsulin-reactive T cells. Our data suggested the notion that CatG plays a critical role in proinsulin processing and is important in the activation process of diabetogenic T cells.

摘要

自身抗原肽来源于自身蛋白,如胰岛素原,是 1 型糖尿病(T1D)发展的重要参与者。自身蛋白可以在细胞内体中被组织蛋白酶(Cats)加工,并加载到主要组织相容性复合体(MHC)II 类分子上,供 CD4+T 细胞检查。然而,抗原呈递细胞(APC)对胰岛素原的加工和呈递在人类中还不完全清楚。在这里,我们证明了 B 细胞或髓样树突状细胞(mDC1)衍生的溶酶体组织蛋白酶对胰岛素原的加工导致了几种胰岛素原衍生的中间产物。这些中间产物与使用纯化的 CatG 获得的中间产物相似,在体外,与 CatD、S 和 V 的作用程度较小。其中一些中间产物在 T1D 患者的外周血单核细胞(PBMC)中极化了 T 细胞的激活,提示存在天然加工的 T 细胞表位。此外,发现 T1D 患者的 PBMC 中 CatG 活性升高,CatG 活性的阻断导致胰岛素原反应性 T 细胞的功能抑制。我们的数据表明,CatG 在胰岛素原加工中起着关键作用,并且在致糖尿病 T 细胞的激活过程中很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/d5b83f58e0f0/pone.0022815.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/1172f776da3e/pone.0022815.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/ac9e2e0c6c62/pone.0022815.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/5b750fe867a1/pone.0022815.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/f060a332f48a/pone.0022815.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/63789f790479/pone.0022815.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/8fd5cc8ba19c/pone.0022815.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/d5b83f58e0f0/pone.0022815.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/1172f776da3e/pone.0022815.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/ac9e2e0c6c62/pone.0022815.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/5b750fe867a1/pone.0022815.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/f060a332f48a/pone.0022815.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/63789f790479/pone.0022815.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/8fd5cc8ba19c/pone.0022815.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5589/3151250/d5b83f58e0f0/pone.0022815.g007.jpg

相似文献

1
Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients.组织蛋白酶 G 的调节可减少来自 1 型糖尿病患者的前胰岛素反应性 T 细胞的激活。
PLoS One. 2011;6(8):e22815. doi: 10.1371/journal.pone.0022815. Epub 2011 Aug 5.
2
Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.不变链加工与原代人 B 细胞/树突状细胞和 B 淋巴细胞母细胞之间的组织蛋白酶变化无关。
Cell Immunol. 2011;269(2):96-103. doi: 10.1016/j.cellimm.2011.03.012. Epub 2011 Mar 17.
3
Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.应用特定的细胞可渗透组织蛋白酶G抑制剂可导致原代树突状细胞中抗原加工减少。
Mol Immunol. 2009 Sep;46(15):2994-9. doi: 10.1016/j.molimm.2009.06.017. Epub 2009 Jul 16.
4
Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus.(前)胰岛素在 MHC Ⅱ类途径中的加工和呈递:1 型糖尿病中基于抗原的免疫调节剂的产生。
Diabetes Metab Res Rev. 2010 May;26(4):227-38. doi: 10.1002/dmrr.1090.
5
Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.组织蛋白酶G的下调可减少小鼠自身免疫性糖尿病中CD4 + T细胞的活化。
Am J Transl Res. 2017 Nov 15;9(11):5127-5137. eCollection 2017.
6
Cathepsin G: roles in antigen presentation and beyond.组织蛋白酶 G:在抗原呈递中的作用及其他作用。
Mol Immunol. 2010 Jan;47(4):658-65. doi: 10.1016/j.molimm.2009.10.003. Epub 2009 Nov 11.
7
A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitus.胰岛素原 74-90 衍生的蛋白酶抗性改变肽配体增加 1 型糖尿病患者 PBMC 中 TGF-β1 的分泌。
J Leukoc Biol. 2010 May;87(5):943-8. doi: 10.1189/jlb.1109713.
8
Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.1 型糖尿病中 T 细胞对源自胰岛素原和 GAD 肽的 Ii-Key/MHC Ⅱ类表位杂合体的识别。
Horm Metab Res. 2011 Jun;43(7):483-8. doi: 10.1055/s-0031-1275705. Epub 2011 Apr 21.
9
A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice.一种针对含胰岛素原融合肽的 TCR 样抗体可改善 NOD 小鼠的 1 型糖尿病。
Biochem Biophys Res Commun. 2021 Jan 1;534:680-686. doi: 10.1016/j.bbrc.2020.11.019. Epub 2020 Nov 15.
10
Proinsulin C-peptide is an autoantigen in people with type 1 diabetes.胰岛素原 C 肽是 1 型糖尿病患者的自身抗原。
Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10732-10737. doi: 10.1073/pnas.1809208115. Epub 2018 Oct 1.

引用本文的文献

1
The duplexity of insulin: The integrated bioinformatics analysis and machine learning identified key genes for type 2 diabetes.胰岛素的双重性:综合生物信息学分析和机器学习确定了2型糖尿病的关键基因。
Biochem Biophys Rep. 2025 Jun 24;43:102099. doi: 10.1016/j.bbrep.2025.102099. eCollection 2025 Sep.
2
Quantifying Protein Acetylation in Diabetic Nephropathy from Formalin-Fixed Paraffin-Embedded Tissue.从福尔马林固定石蜡包埋组织中定量糖尿病肾病中的蛋白质乙酰化。
Proteomics Clin Appl. 2024 Nov;18(6):e202400018. doi: 10.1002/prca.202400018. Epub 2024 Jun 24.
3
Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection.

本文引用的文献

1
Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.不变链加工与原代人 B 细胞/树突状细胞和 B 淋巴细胞母细胞之间的组织蛋白酶变化无关。
Cell Immunol. 2011;269(2):96-103. doi: 10.1016/j.cellimm.2011.03.012. Epub 2011 Mar 17.
2
Was the serine protease cathepsin G discovered by S. G. Hedin in 1903 in bovine spleen?丝氨酸蛋白酶组织蛋白酶G是由S. G. 赫丁于1903年在牛脾脏中发现的吗?
Acta Biochim Pol. 2011;58(1):39-44. Epub 2011 Mar 7.
3
How immune peptidases change specificity: cathepsin G gained tryptic function but lost efficiency during primate evolution.
自身免疫性 CD8+ T 细胞在 1 型糖尿病中的作用:从单细胞 RNA 测序到 T 细胞受体重定向。
Front Endocrinol (Lausanne). 2024 May 10;15:1377322. doi: 10.3389/fendo.2024.1377322. eCollection 2024.
4
Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation.丝氨酸蛋白酶抑制剂对中性粒细胞衍生丝氨酸蛋白酶蛋白水解活性的阻碍作用在心血管疾病和慢性炎症管理中的应用
Front Chem. 2021 Nov 15;9:784003. doi: 10.3389/fchem.2021.784003. eCollection 2021.
5
Cathepsin C Regulates Cytokine-Induced Apoptosis in β-Cell Model Systems.组织蛋白酶 C 调控β细胞模型系统细胞因子诱导的细胞凋亡。
Genes (Basel). 2021 Oct 25;12(11):1694. doi: 10.3390/genes12111694.
6
Activity-Based Probes to Utilize the Proteolytic Activity of Cathepsin G in Biological Samples.基于活性的探针,用于利用生物样品中组织蛋白酶G的蛋白水解活性。
Front Chem. 2021 Feb 25;9:628295. doi: 10.3389/fchem.2021.628295. eCollection 2021.
7
Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.靶向 Her2 的丝纳米球的细胞摄取、细胞内分布和降解。
Int J Nanomedicine. 2019 Aug 26;14:6855-6865. doi: 10.2147/IJN.S217854. eCollection 2019.
8
Orchestration of Adaptive T Cell Responses by Neutrophil Granule Contents.中性粒细胞颗粒内容物对适应性 T 细胞应答的调控。
Mediators Inflamm. 2019 Mar 10;2019:8968943. doi: 10.1155/2019/8968943. eCollection 2019.
9
Cathepsin G and Its Role in Inflammation and Autoimmune Diseases.组织蛋白酶G及其在炎症和自身免疫性疾病中的作用。
Arch Rheumatol. 2018 Jan 22;33(4):498-504. doi: 10.5606/ArchRheumatol.2018.6595. eCollection 2018 Dec.
10
Role of cathepsin S In periodontal wound healing-an in vitro study on human PDL cells.组织蛋白酶S在牙周伤口愈合中的作用——一项关于人牙周膜细胞的体外研究
BMC Oral Health. 2018 Apr 5;18(1):60. doi: 10.1186/s12903-018-0518-2.
免疫肽酶如何改变特异性:组织蛋白酶 G 在灵长类动物进化过程中获得胰蛋白酶功能但丧失效率。
J Immunol. 2010 Nov 1;185(9):5360-8. doi: 10.4049/jimmunol.1002292. Epub 2010 Oct 1.
4
Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus.(前)胰岛素在 MHC Ⅱ类途径中的加工和呈递:1 型糖尿病中基于抗原的免疫调节剂的产生。
Diabetes Metab Res Rev. 2010 May;26(4):227-38. doi: 10.1002/dmrr.1090.
5
Cathepsin G: roles in antigen presentation and beyond.组织蛋白酶 G:在抗原呈递中的作用及其他作用。
Mol Immunol. 2010 Jan;47(4):658-65. doi: 10.1016/j.molimm.2009.10.003. Epub 2009 Nov 11.
6
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.1,25-二羟基维生素D3与白细胞介素-2联合抑制T细胞炎性细胞因子的产生,并促进表达细胞毒性T淋巴细胞相关抗原4(CTLA-4)和叉头框蛋白3(FoxP3)的调节性T细胞的发育。
J Immunol. 2009 Nov 1;183(9):5458-67. doi: 10.4049/jimmunol.0803217.
7
Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.组织蛋白酶 S、L 和 B 在 NOD 小鼠胰岛炎和糖尿病中的作用。
J Autoimmun. 2010 Mar;34(2):96-104. doi: 10.1016/j.jaut.2009.07.003. Epub 2009 Aug 6.
8
Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincense.鉴定人组织蛋白酶G为抗炎药物乳香中乳香酸的功能靶点。
J Immunol. 2009 Sep 1;183(5):3433-42. doi: 10.4049/jimmunol.0803574. Epub 2009 Jul 31.
9
Diverse regulatory roles for lysosomal proteases in the immune response.溶酶体蛋白酶在免疫反应中的多种调节作用。
Eur J Immunol. 2009 Nov;39(11):2955-65. doi: 10.1002/eji.200939650.
10
Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.应用特定的细胞可渗透组织蛋白酶G抑制剂可导致原代树突状细胞中抗原加工减少。
Mol Immunol. 2009 Sep;46(15):2994-9. doi: 10.1016/j.molimm.2009.06.017. Epub 2009 Jul 16.